Anzeige
Mehr »
Login
Mittwoch, 22.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
STRONG BUY! Kurs eskaliert - A Star is Born!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 906169 | ISIN: CA66510M2040 | Ticker-Symbol: ND3
Tradegate
21.01.25
21:56 Uhr
0,658 Euro
+0,010
+1,47 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
NORTHERN DYNASTY MINERALS LTD Chart 1 Jahr
5-Tage-Chart
NORTHERN DYNASTY MINERALS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,6370,66421.01.
0,6250,67121.01.
ACCESS Newswire
671 Leser
Artikel bewerten:
(2)

Northern Dynasty Minerals Ltd.: Alaska Governor Asks Trump to Prioritize Alaska-Specific Executive Order to Simplify Permitting

Finanznachrichten News

VANCOUVER, BC / ACCESSWIRE / December 20, 2024 / Northern Dynasty Minerals Ltd. (TSX:NDM)(NYSE American:NAK) ("Northern Dynasty" or the "Company") and 100%-owned U.S.-based subsidiary Pebble Limited Partnership ("Pebble Partnership" or "PLP") advise that Alaska Governor Mike Dunleavy recently sent a report entitled "Alaska Priorities for Federal Transition" to President-elect Donald Trump along with a letter, asking that the President-elect issue an Alaska-specific Executive Order on his first day in office reversing several unfriendly resource extraction initiatives put in place by the Biden Administration.

Included in the document are many recommendations including, but not limited to, simplification of the Clean Water Act regulations consistent with the Supreme Court Sackett decision on the definition of Waters of the United States, the requirement for State Approval for 404 (c) vetoes under certain conditions, and that changes be made to compensatory mitigation requirements to account for Alaska's unique characteristics.

"We would like to say we are in agreement with all of the Governor's requests as they will enhance the permitting process, which will allow an unbiased science and fact-based regulatory oversight and process, helping the U.S. to achieve security of supply of critical metals from American/Alaskan sources. In particular, we see that a number of the requests relate to the Clean Water Act regulations as set out above (Sacket decision), and to several of the findings and directions within the Remand Order issued by US Army Corps of Engineers Administrative Appeal of our Record of Decision denial," said Ron Thiessen, Northern Dynasty President and CEO. "The recommendations would empower the State's right to direct and oversee the permitting process, particularly on State lands, reduce agency overreach and duplication of work among federal agencies, simplify the permitting process and help unlock the State's vast critical mineral potential for the benefit of all Americans."

The full report can be found at the following link: https://gov.alaska.gov/dunleavy-administration-submits-transition-report-to-trump-transition-hq/.

About Northern Dynasty Minerals Ltd.
Northern Dynasty is a mineral exploration and development company based in Vancouver, Canada. Northern Dynasty's principal asset, owned through its wholly owned Alaska-based U.S. subsidiary, Pebble Limited Partnership, is a 100% interest in a contiguous block of 1,840 mineral claims in Southwest Alaska, including the Pebble deposit, located 200 miles from Anchorage and 125 miles from Bristol Bay. The Pebble Partnership is the proponent of the Pebble Project.

For further details on Northern Dynasty and the Pebble Project, please visit the Company's website at www.northerndynastyminerals.com or contact Investor services at (604) 684-6365 or within North America at 1- 800-667-2114. Public filings, which include forward-looking information cautionary language and risk factor disclosure regarding the Company and the Pebble Project can be found in Canada at www.sedarplus.ca and in the United States at www.sec.gov.

Ronald W. Thiessen
President & CEO

U.S. Media Contact:
Dan Gagnier, Gagnier Communications (646) 569-5897

Forward-Looking Information and other Cautionary Factors
This release includes certain statements that may be deemed "forward-looking statements" under the United States Private Securities Litigation Reform Act of 1995 and under applicable provisions of Canadian provincial securities laws. All statements in this release, other than statements of historical facts, which address permitting, development and production for the Pebble Project are forward-looking statements.

Forward-looking statements are necessarily based upon a number of factors and assumptions that, while considered reasonable by NDM as of the date of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies and such statements should not be in any way be construed as guarantees that the Pebble Project will secure all required government permits, establish the commercial feasibility of the Pebble Project, achieve the required financing or develop the Pebble Project.

For more information on the Company, Investors should review the Company's filings with the United States Securities and Exchange Commission at www.sec.gov and its home jurisdiction filings that are available at www.sedarplus.ca.

SOURCE: Northern Dynasty Minerals Ltd.



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.